Pneumococcal meningitis: Clinical course and resource use in Western Australian children

Journal of Paediatrics and Child Health

Volumn 40, Issue 11, 2004, Pages 606-610

  King, B A ^a,c   Richmond, P ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Diagnosis of meningitis; Meningitis; Pneumococcus

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; AUSTRALIA; BACTERIAL MENINGITIS; CHILD; CHILDHOOD DISEASE; DISEASE COURSE; DISEASE DURATION; FEMALE; HEALTH CARE COST; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RESOURCE ALLOCATION; RETROSPECTIVE STUDY; REVIEW; RURAL AREA; SEIZURE; SEROTYPE; STREPTOCOCCUS INFECTION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, PNEUMOCOCCAL; PENICILLIN RESISTANCE; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES; RISK FACTORS; RURAL POPULATION; STATISTICS, NONPARAMETRIC; TIME FACTORS; URBAN POPULATION; VACCINES, CONJUGATE; WESTERN AUSTRALIA;

EID: 8744236890     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2004.00485.x     Document Type: Review

References (17)

1. McIntyre P, Gidding H, Gilmour R et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999-2000. Communicable Diseases Intelligence 2002; 26: S1-111. Available from URL: http://www.cda.gov.au/pubs/cdi/2002/ cdi26suppl/ vpd99_00.htm
2. McIntyre PB, Nolan TM. Conjugate pneumococcal vaccines for non-Indigenous children in Australia. Med. J. Aust. 2000; 173 (Suppl.): S54-S57.
3. Black S, Shinefield H, Fireman B et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 2000; 19: 187-95.
4. Bohr V, Rasmussen N, Hansen B et al. Pneumococcal meningitis: an evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae. J. Infect. 1985; 10: 143-57.
5. Kornelisse RF, Westerbeek CM, Spoor AB et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin. Infect. Dis. 1995; 21: 1390-7.
6. Arditi M, Mason EO Jr, Bradley JS et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998; 102: 1087-97.
7. Laxer RM, Marks MI. Pneumococcal meningitis in children. Am. J. Dis. Child 1977; 131: 850-3.
8. Voss L, Lennon D, Okensene-Gafa K et al. Invasive pneumococcal disease in a paediatric population, Auckland, New Zealand. Pediatr. Infect. Dis. J. 1994; 13: 873-8.
9. Kirkpatrick B, Reeves DS, MacGowan AP. A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults. J. Infect. 1994; 29: 171-82.
10. Mackie EJ, Shears P, Frimpong E, Mustafa-Kutana SN. A study of bacterial meningitis in Kumasi, Ghana. Ann. Trop. Paediatr. 1992; 12: 143-8.
11. Goetghebuer T, West TE, Wermenbol V et al. Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia. Trop. Med. Int. Health 2000; 5: 207-13.
12. Bedford H, de Louvois J, Halket S et al. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ 2001; 323: 533-6.
13. Pikis A, Kavaliotis J, Tsikoulas J et al. Long-term sequelae of pneumococcal meningitis in children. Clin. Pediatr. 1996; 35: 72-8.
14. McIntyre PB, Gilmour RE, Gilbert GL et al. Epidemiology of invasive pneumococcal disease in urban New South Wales, 1997-99. Med. J. Aust. 2000; 173 (Suppl.): S22-31.
15. McMaster P, McIntyre P, Gilmour L, Kakakios Mellis C. The emergence of resistant pneumococcal meningitis - implications for empiric therapy. Arch. Dis. Child 2002; 87: 207-11.
16. Lebel MH, Kellner JD, Ford-Jones EL et al. A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in Canada. Clin. Infect. Dis. 2003; 36: 259-68.
17. Lieu TA, Ray GT, Black SB et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA 2000; 283: 1460-8.